Ohnishi Kazunori | Shikoku National Hospital Matsuyama Jpn
スポンサーリンク
概要
関連著者
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Osaki Koichi
九州厚生年金病院
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
三木 義男
癌研ゲノムセンター
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Nakagawa Shun-ichi
鈴鹿中央総合病院(厚生連)
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
Akashi Koichi
九州大学 医学研究院病態修復内科学
-
Akashi Koichi
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
ANDO Kiyoshi
Tokai University
-
OHNO Ryuzo
Aichi Cancer Center
-
谷脇 雅文
高知工科大学工学部
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Ando Kiyoshi
Division of Hematology and Oncology, Tokai University School of Medicine
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Takahashi Masatomo
聖マリアンナ医科大学 血液・腫瘍内科
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
Tanimoto Kazuki
国立がんセンター中央病院
-
Uike N
National Kyusyu Cancer Center
-
Yokozawa Toshiya
豊橋市民病院 血液・腫瘍内科
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
TAWARA Masayuki
Nagasaki CML Study Group
-
MEGURO KUNIAKI
National Sendai Hospital
-
三木 義男
東京医歯大 難治疾患研 疾患医科学研究系分子遺伝分野
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Minauchi Koichiro
Second Department Of Medicine Hokkaido University Graduate School Of Medicine
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Graduated School Of Medicine
-
Tateishi Ukihide
Yokohama City Univ. Kanagawa Jpn
-
Tateishi Ukihide
Department Of Radiology Yokohama City University School Of Medicine
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Hospital Graduate School Of Medicine
-
Tateishi Ukihide
国立がんセンター中央病院 放射線診断部
-
Hotta Tomomitsu
National Hospital Organization Nagoya Medical Center
-
Hotta Tomomitsu
国立がんセンター中央病院 血液内科
-
Hotta Tomomitsu
東海大学 医学研究科血液腫瘍内科
-
Chou Takaaki
東海大学 医学部
-
Chou Takaaki
Department Of Internal Medicine Niigata Cancer Center Hospital
-
Chou Takaaki
中華人民共和国
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Yoshida Takashi
Department Of Pathology Okayama University
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
神戸大学 医学研究科腫瘍内科学
-
Itoh K
Department Of Chemistry Faculty Of Science Kobe University
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
永井 正
自治医科大学内科学講座血液学部門
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
永井 正
自治医科大学 内科学講座血液学部門
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Shimoda Kazuya
九州大学 第1内科
-
Tateishi Ukihide
国立がんセンター中央病院 画像診断グループ
-
Tateishi Ukihide
Department Of Diagnostic Radiology Graduate School Of Medicine Yokohama City University
-
Takeyama Kunihiko
東海大学 医学部
-
NAOE Tomoki
Nagoya University
-
YAMAGUCHI Toshikazu
Development of Clinical Genomics, BML
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
ISHIKAWA Yuichi
Department of Pathology, the Cancer Institute of JFCR
-
SUZUKI Yoshihiko
Suzuki clinic
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Yoshida S
Chiba University
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
YOKOYAMA Hiroki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Tobinai Kensei
東海大学 医学部
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
MIYAZAKI Koji
Departments of Surgery, Saga Medical School
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
NAJIMA Yuho
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KAWAMURA Machiko
Pediatrics Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
ONOZUKA Yuji
Development of Clinical Genomics
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
ASANO Naoko
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center
-
ISHIDA Fumihiro
Department of Internal Medicine, Shinshu University School of Medicine
-
OGAWA Hiroshi
Department of Pathology, Seirei Mikatahara General Hospital
-
YOSHIMURA Kenichi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
OKAMOTO Rumiko
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
HIRANO Masami
Department of Hematology, Fujita Health University School of Medicine
-
ASAOKU Hideki
Clinical Laboratory, Hiroshima Red Cross Hospital, Atomic-Bomb Survivors Hospital
-
KUROSAWA Mitsutoshi
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center
-
MAEDA Yoshiharu
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
OMACHI Ken
Department of Hematology and Oncology, Tokai University School of Medicine
-
KASAI Masaharu
Department of Hematology, Sapporo Hokuyu Hospital
-
TAKAYAMA Nobuyuki
Second Department of Internal Medicine, Kyorin University
-
KABA Harumi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
YAMAMOTO Seiichiro
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
FUKUDA Haruhiko
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
KIKUCHI Masahiro
Department of Pathology, School of Medicine, Fukuoka University
-
HOTTA Tomomitsu
National Hospital Organization, Nagoya Medical Center
-
HANAMURA Akitoshi
Department of Hematology, Gifu Prefectural Tajimi Hospital
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
HIGASHIHARA Masaaki
Department of Hematology, Kitasato University School of Medicine
-
Ueda R
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
Aoki Sadao
Division of Hematology and Cardiology, Graduate School of Medical and Dental Science, Niigata Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
JINNAI Itsuro
Nagasaki CML Study Group
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
OHYASHIKI Kazuma
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
KASAI Masanobu
Department of Hematology, Nagoya Daini Red Cross Hospital
-
KUBO Kohmei
Department of Hematology, Aomori Prefectural Central Hospital
-
Seino Yoshihiko
Department Of Internal Medicine Cardiovascular Center Nippon Medical School Chiba-hokusoh Hospital
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
Tomonari Akira
東京大学医科学研究所附属病院 血液腫瘍内科
-
Tomonari Akira
Department Of Hematology/oncology The Institute Of Medical Science The University Of Tokyo
-
Tomonari Akira
Department Of Hematology/oncology
-
ISHIZAWA Kenichi
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
YAMAMOTO Joji
Department of Hematology and Rheumatology, Tohoku University Hospital
-
Komatsu Hirokazu
名古屋市立大学 医学研究科腫瘍・免疫内科学
-
Tsuchiya S
Department Of Pediatrics Tohoku University School Of Medicine
-
Muta K
Department Of Pathology School Of Medicine Fukuoka University
-
ISHIDA Yoji
Division of Hematology/Oncology, Iwate Medical University School of Medicine
-
Hatsumi Naoko
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Akashi K
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Takeuchi T
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takeuchi Takahiro
愛知県立がんセンター病院
-
HATAKE Kiyohiko
Cancer Institute Hospital
-
Sasaki Takeshi
Department Of Infection Control And Laboratory Diagnostics Tohoku University Graduate School Of Medi
-
TAKENAKA Takeaki
Hematology Division, National Cancer Center Hospital
-
Seriu Taku
国立がんセンター中央病院
-
Seriu Taku
Bristol-myers K.k.
-
Terauchi Takashi
国立がんセンター中央病院 血液内科
-
Uike Naokuni
The Department Of Hematology National Kyushu Cancer Center Hospital
-
Yokozawa Toshiya
Clinical Research Center National Hospital Organization Nagoya Medical Center
-
Yokozawa T
Nagoya Univ. Graduate Schol Of Medicine Nagoya Jpn
-
Yokozawa T
Hematology Division National Cancer Center Hospital
-
Yokozawa Toshiya
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Yokozawa Toshiya
Division Of Hematology Nagoya Medical Center
-
DAN Kazuo
Division of Hematology, Department of Internal Medicine, Nippon Medical School
-
KAMATA Noriko
Department of Radiology, Tokyo Metropolitan Komagome Hospital
-
Yoshino T
Division Of Pathology Okayama University Hospital
-
Yoshino Tadashi
岡山大学 医歯薬学総合研究科血液・腫瘍・呼吸器・アレルギー内科
-
Kubota Nobuko
国立がんセンター中央病院
-
Kubota Nobuko
Hematology Division National Cancer Center Hospital
-
TANIWAKI Masafumi
Kyoto Prefectural University of Medicine
-
FUJISAWA Shin
Yokohama City University Medical Center
-
USUI Noriko
Jikei University School of Medicine
-
NAGAI Tadashi
Jichi Medical School
-
MOTOJI Toshiko
Tokyo Women's Medical University
著作論文
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Vasodilator Stress Impairs the Left Ventricular Function Obtained With Gated Single-Photon Emission Computed Tomography in Patients With Known or Suspected Coronary Artery Disease
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments
- Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Osteonecrosis of the humeral head
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study